Atlas Trials

Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer

Clinical trial NCT04465097 · COMPLETED

Trial details

NCT number
NCT04465097
Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2020-07-08
Primary completion
2023-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.